New JAK2 inhibitors for myeloproliferative neoplasms.
Quintás-Cardama, Alfonso
New JAK2 inhibitors for myeloproliferative neoplasms. [electronic resource] - Expert opinion on investigational drugs Jul 2011 - 961-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1744-7658
10.1517/13543784.2011.579560 doi
Animals
Bone Marrow Neoplasms--drug therapy
Clinical Trials as Topic--methods
Humans
Janus Kinase 2--antagonists & inhibitors
Mutation--genetics
Myeloproliferative Disorders--drug therapy
Protein Kinase Inhibitors--pharmacology
Signal Transduction--drug effects
New JAK2 inhibitors for myeloproliferative neoplasms. [electronic resource] - Expert opinion on investigational drugs Jul 2011 - 961-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1744-7658
10.1517/13543784.2011.579560 doi
Animals
Bone Marrow Neoplasms--drug therapy
Clinical Trials as Topic--methods
Humans
Janus Kinase 2--antagonists & inhibitors
Mutation--genetics
Myeloproliferative Disorders--drug therapy
Protein Kinase Inhibitors--pharmacology
Signal Transduction--drug effects